What Is Cryotherapy

Cryotherapy is the controlled application of extreme cold to the body for therapeutic purposes. Whole-body cryotherapy (WBC) typically involves standing in a chamber cooled by liquid nitrogen or refrigerated air to temperatures between negative 100 and negative 180 degrees Celsius for two to four minutes. Localized cryotherapy applies cold to specific body regions using targeted devices, ice packs, or cold-air applicators.

Cold exposure triggers a cascade of physiological responses that intersect with several pathways relevant to aging and resilience. When the body detects a rapid drop in skin temperature, it vasoconstricts peripheral blood vessels, redirects blood to the core, and activates the sympathetic nervous system. This acute stress response elevates norepinephrine, which plays roles in attention, mood, and inflammation modulation. Over repeated exposures, the body can develop improved cold tolerance and more efficient thermoregulatory responses, a form of hormetic adaptation where a controlled stressor strengthens the organism's capacity to handle future challenges.

From a longevity perspective, the anti-inflammatory effects are of particular interest. Chronic low-grade inflammation, sometimes called inflammaging, is a hallmark of biological aging and a contributor to cardiovascular disease, neurodegeneration, and metabolic decline. If cryotherapy reliably dampens inflammatory signaling without suppressing beneficial immune function, it could serve as one tool in a broader strategy to manage inflammatory burden. The activation of cold-shock proteins such as RBM3, observed in preclinical models, also connects to neuroprotective and cellular-repair pathways, though human data on these specific proteins in the context of cryotherapy remains limited.

When skin temperature drops rapidly during a cryotherapy session, thermoreceptors in the skin send urgent signals through afferent nerve fibers to the hypothalamus, the brain's thermoregulatory center. The hypothalamus initiates a sympathetic nervous system response: peripheral vasoconstriction limits heat loss from the extremities, heart rate increases, and blood pressure rises transiently. Norepinephrine release can increase two to threefold, which suppresses pro-inflammatory cytokines such as TNF-alpha and IL-1beta while enhancing alertness and mood.

At the tissue level, the cold reduces nerve conduction velocity, which blunts pain signaling, a principle long used in sports medicine for acute injury management. Vasoconstriction followed by post-session vasodilation creates a vascular pumping effect that may assist in clearing metabolic waste products from muscles. The transient reduction in tissue metabolism also limits secondary hypoxic injury in inflamed or damaged tissues, slowing the biochemical reactions that propagate tissue damage after the initial insult.

Repeated cold exposure appears to upregulate mitochondrial uncoupling protein 1 (UCP1) in brown adipose tissue, increasing non-shivering thermogenesis. This metabolic pathway converts stored energy directly into heat rather than ATP, a process that has implications for metabolic flexibility and glucose regulation. Cold exposure also stimulates the release of cold-shock proteins, particularly RBM3, which in animal models has demonstrated roles in synapse regeneration and protection against neurodegeneration. The extent to which standard cryotherapy protocols activate these deeper molecular pathways in humans, as opposed to more prolonged or intense cold-water immersion, is still being characterized.

A typical whole-body cryotherapy session begins with a brief intake where staff check for contraindications and explain the procedure. You will change into minimal clothing (shorts, sports bra for women, socks, gloves, and sometimes a headband or face mask to protect the ears and nose). In a walk-in chamber, the room cools to the target temperature and you enter for two to four minutes. In a single-person cryosauna, your head remains above the chamber while your body is enveloped in nitrogen-cooled air.

During the session, the cold is intense but dry, which most people find more tolerable than ice-water immersion. You may be asked to slowly rotate or move your arms. Staff typically monitor you through a window or remain nearby. Upon exiting, you will notice rapid skin reddening and a surge of alertness as norepinephrine levels peak. Many people report improved mood and reduced muscle soreness within 15 to 30 minutes. The entire visit, including preparation and recovery time, usually takes 15 to 20 minutes.

Session duration for whole-body cryotherapy ranges from two to four minutes, with most facilities capping sessions at three minutes for new clients. Localized cryotherapy treatments may last five to ten minutes per targeted area. For general recovery and wellness, two to three sessions per week is a common protocol. Athletes during intense training blocks sometimes use daily sessions for short periods.

The effects of a single session, particularly on pain perception and mood, tend to be transient, lasting hours rather than days. Sustained benefits, including improved sleep quality, reduced baseline soreness, and better cold tolerance, typically emerge after several weeks of consistent use. There is no strong evidence that daily long-term use provides additional benefits over a few sessions per week, and some practitioners recommend periodic breaks to maintain the hormetic stimulus rather than allowing full adaptation.

A single whole-body cryotherapy session typically costs between $40 and $100 at dedicated cryotherapy studios or recovery centers, with prices varying by location and facility type. Many studios offer packages or memberships that bring the per-session cost down to $25 to $50. Monthly unlimited plans, where available, generally range from $200 to $400. Localized cryotherapy sessions tend to cost less, often $25 to $60 per treatment. Home cryotherapy units exist but represent a significant investment, ranging from a few thousand dollars for basic cold-air devices to $30,000 or more for full walk-in chambers. Insurance does not typically cover cryotherapy for wellness or recovery purposes, though some plans may cover it when prescribed for specific medical conditions such as certain dermatological treatments.

The evidence base for cryotherapy is growing but uneven. Multiple randomized controlled trials in athletic populations show that whole-body cryotherapy can reduce subjective measures of muscle soreness and perceived fatigue after intense exercise, with effects comparable to cold-water immersion in some comparisons. Acute reductions in circulating inflammatory markers have been documented in several small trials, though effect sizes vary and study designs often lack adequate blinding (participants generally know whether they received a cold treatment). A number of systematic reviews have concluded that the evidence for cryotherapy's effects on objective recovery metrics, such as muscle strength restoration or performance markers, is less consistent than the subjective benefits.

Research on cryotherapy for chronic pain conditions, including rheumatoid arthritis and fibromyalgia, is preliminary but shows some signal for symptom improvement. Studies on metabolic outcomes, brown fat activation, and long-term inflammatory modulation in humans are sparse and mostly observational. The cold-shock protein research, particularly around RBM3 and neuroprotection, draws heavily from animal models and cold-water immersion rather than air-based cryotherapy specifically. Dose-response relationships, including optimal temperature, session duration, and frequency, remain poorly defined. Large-scale, long-term trials examining cryotherapy's effects on aging biomarkers or hard health outcomes have not yet been conducted.

Common side effects include transient skin redness, tingling, and numbness that resolves within minutes of exiting the chamber. Frostbite and cold burns can occur with improper equipment, inadequate protective gear on extremities, or sessions that exceed recommended duration. The acute sympathetic activation raises blood pressure and heart rate, which poses risk for individuals with uncontrolled cardiovascular disease. Rare cases of asphyxiation have been reported in nitrogen-cooled single-person chambers when ventilation was inadequate, making supervised, well-maintained facilities important. People with Raynaud's disease, cold urticaria, cryoglobulinemia, or peripheral neuropathy should avoid whole-body cryotherapy. Those on blood thinners or with impaired sensation in the extremities face elevated risk of cold injury without appropriate awareness of tissue response.